Chapter

Toxoplasmosis

Oliver Liesenfeld and Eskild Petersen

in Oxford Textbook of Medicine

Fifth edition

Published on behalf of Oxford University Press

ISBN: 9780199204854
Published online May 2012 | e-ISBN: 9780199570973 | DOI: http://dx.doi.org/10.1093/med/9780199204854.003.070804_update_002

Series: Oxford Textbooks

Toxoplasmosis

More Like This

Show all results sharing these subjects:

  • Medical Microbiology and Virology
  • Infectious Diseases

GO

Show Summary Details

Preview

Toxoplasma gondii is a protozoan parasite with worldwide distribution that infects up to one-third of the world’s population. Human infection is acquired through ingestion in water or food of oocysts shed by cats, or by ingestion of bradyzoites released from cysts contained in uncooked or undercooked meat (e.g. sheep, swine, cattle). Following invasion in the intestine, tachyzoites rapidly disseminate throughout the host. Immune mechanisms mediate the formation of cysts, primarily in the brain, eye, and skeletal and heart muscles, where they persist for the life of the host. Presence of infection may be established by direct detection of the parasite in clinical samples (often by polymeric chain reaction, PCR) or by serological techniques.

Clinical features and treatment

Immunocompetent adults and children—primary infection is usually subclinical, but some patients develop cervical lymphadenopathy; specific treatment is not usually required.

Ocular disease—choroidoretinitis; treatment with pyrimethamine and sulphadiazine is usually recommended if there are severe inflammatory responses and/or proximity of retinal lesions to the fovea or optic disk.

Immunocompromised patients—the central nervous system is the most commonly affected site. Reactivation of latent infection can cause life-threatening encephalitis. Empirical anti-T. gondii therapy is given to patients with single or multiple ring-enhancing brain lesions on imaging, positive serology, and advanced immunodeficiency, most commonly with the combination of pyrimethamine/sulphadiazine and folinic acid.

Congenital toxoplasmosis—infection acquired in early pregnancy may cause severe damage to the fetus or intrauterine death; infection in the second and third trimesters goes unnoticed in the newborn in most cases, but signs of disease, e.g. chorioretinitis, may occur later in life. Suspected or established maternal infection acquired during pregnancy must be confirmed by prenatal diagnosis of fetal infection using PCR on amniotic fluid: if this is positive it is highly probable that the fetus is infected and pyrimethamine/sulphadiazine and folinic acid should be given and continued throughout the pregnancy.

Prevention

Prevention of infection by avoiding ingestion is the strategy of choice in seronegative people. Pyrimethamine sulphadiatine can be used for primary and secondary prophylaxis of seropositive immunocompromised patients or seronegative recipients of organ transplants from seropositive donors. Spiramycin can be used for secondary prevention of transmission from the acutely infected mother to her fetus.

Chapter.  4712 words.  Illustrated.

Subjects: Medical Microbiology and Virology ; Infectious Diseases

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.